Evidence map›Paper›PMID 34244528›Full record

ArticleScientific reports2021

Insights into the molecular properties underlying antibacterial activity of prenylated (iso)flavonoids against MRSA.

Sylvia Kalli, Carla Araya-Cloutier, Jos Hageman, Jean-Paul Vincken

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Polyphenolic compounds inFrontiers in pharmacology · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Phytochemistry reviews : proceedings of the Phytochemical Society of Europe · 2023
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sylvia KalliLaboratory of Food Chemistry, Wageningen University & Research, Wageningen, The Netherlands.
Carla Araya-CloutierLaboratory of Food Chemistry, Wageningen University & Research, Wageningen, The Netherlands.
Jos HagemanBiometris, Applied Statistics, Wageningen University & Research, Wageningen, The Netherlands.
Jean-Paul VinckenLaboratory of Food Chemistry, Wageningen University & Research, Wageningen, The Netherlands. jean-paul.vincken@wur.nl.
Wageningen University & Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High resistance towards traditional antibiotics has urged the development of new, natural therapeutics against methicillin-resistant Staphylococcus aureus (MRSA). Prenylated (iso)flavonoids, present mainly in the Fabaceae, can serve as promising candidates. Herein, the anti-MRSA properties of 23 prenylated (iso)flavonoids were assessed in-vitro. The di-prenylated (iso)flavonoids, glabrol (flavanone) and 6,8-diprenyl genistein (isoflavone), together with the mono-prenylated, 4'-O-methyl glabridin (isoflavan), were the most active anti-MRSA compounds (Minimum Inhibitory Concentrations (MIC) ≤ 10 µg/mL, 30 µM). The in-house activity data was complemented with literature data to yield an extended, curated dataset of 67 molecules for the development of robust in-silico prediction models. A QSAR model having a good fit (R

Indexed as

Anti-Bacterial AgentsFlavonoidsHumansIsoflavonesMethicillin-Resistant Staphylococcus aureusPhenolsPrenylationStaphylococcal InfectionsAnti-Bacterial AgentsFlavonoidsglabridinglabrolIsoflavonesPhenols

Identifiers

PMID34244528
PMCPMC8270993
OpenAlexW3180164387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.